NCT00252057

Brief Summary

The purpose of this study is to determine if the "Re-Engineered Discharge" will decrease rehospitalization rates and adverse events of patients leaving Boston Medical Center.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
749

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2005

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 11, 2005

Completed
20 days until next milestone

Study Start

First participant enrolled

December 1, 2005

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

April 13, 2009

Completed
Last Updated

March 28, 2017

Status Verified

February 1, 2017

Enrollment Period

1.8 years

First QC Date

November 10, 2005

Results QC Date

February 10, 2009

Last Update Submit

February 27, 2017

Conditions

Keywords

rehospitalizationreadmissionadverse eventsdischarge

Outcome Measures

Primary Outcomes (1)

  • Total Number of Rehospitalizations (Emergency Department Visits Plus Hospital Admissions) in the 30 Days After Discharge.

    The total number of rehospitalizations (emergency department visits plus hospital admissions) in the 30 days after discharge, compared across study arms. Participants could have more than one rehospitalization in this period; all rehospitalizations for each were counted, making the unit of measure the rehospitalizations and not the participants.

    30 days after discharge

Study Arms (2)

Re-engineered hospital discharge

EXPERIMENTAL

Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.

Behavioral: Re-Engineered Hospital Discharge

Standard hospital discharge

NO INTERVENTION

Participants received the routine, standard hospital discharge.

Interventions

The "Re-engineered Hospital Discharge" (Project RED) intervention provides a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call after discharge by a clinical pharmacist.

Also known as: RED
Re-engineered hospital discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • are over 18 years old;
  • are to be discharged to a community, non-institutionalized setting;
  • report that they desire to be hospitalized in the future if there is a clinical need; and
  • are admitted to Firm B of the BMC Inpatient Service.
  • admitted to non-general Medical services at BMC (e.g., orthopedic surgery, obstetrics and gynecology, otolaryngology, general surgery, or psychiatry);
  • requiring hospice, nursing home or other institutional settings upon discharge,
  • who die during the admission,
  • subjects who speak languages other than English;
  • those who indicate that they have no access to a telephone or unable to give a contact telephone number; and
  • those not competent to sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Medical center

Boston, Massachusetts, 02118, United States

Location

Related Publications (3)

  • Woz S, Mitchell S, Hesko C, Paasche-Orlow M, Greenwald J, Chetty VK, O'Donnell J, Jack B. Gender as risk factor for 30 days post-discharge hospital utilisation: a secondary data analysis. BMJ Open. 2012 Apr 18;2(2):e000428. doi: 10.1136/bmjopen-2011-000428. Print 2012.

  • Mitchell SE, Paasche-Orlow MK, Forsythe SR, Chetty VK, O'Donnell JK, Greenwald JL, Culpepper L, Jack BW. Post-discharge hospital utilization among adult medical inpatients with depressive symptoms. J Hosp Med. 2010 Sep;5(7):378-84. doi: 10.1002/jhm.673.

  • Jack BW, Chetty VK, Anthony D, Greenwald JL, Sanchez GM, Johnson AE, Forsythe SR, O'Donnell JK, Paasche-Orlow MK, Manasseh C, Martin S, Culpepper L. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009 Feb 3;150(3):178-87. doi: 10.7326/0003-4819-150-3-200902030-00007.

Related Links

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

Leukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Results Point of Contact

Title
Brian Jack PI
Organization
Boston Medical Center

Study Officials

  • Brian Jack, MD

    Boston Medical Center - Family Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

November 10, 2005

First Posted

November 11, 2005

Study Start

December 1, 2005

Primary Completion

October 1, 2007

Study Completion

October 1, 2007

Last Updated

March 28, 2017

Results First Posted

April 13, 2009

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

Locations